[1]JournalofMedicinalChemistry,1998,vol.41,p.2442-2444
[2]Patent:US5516774,1996,A
[3]Patent:US5733905,1998,A
[4]Patent:US5736540,1998,A
168079-32-1
[1]BioorganicandMedicinalChemistryLetters,2000,vol.10,p.783-786
[2]Patent:EP1021444,2003,B1.Locationinpatent:Page/Pagecolumn19
[1]BioorganicandMedicinalChemistryLetters,2000,vol.10,p.783-786
[2]Patent:EP1021444,2003,B1
[1]JournalofMedicinalChemistry,1998,vol.41,p.2442-2444
[1]JournalofMedicinalChemistry,1998,vol.41,p.2442-2444
Title: [Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960) 20120101
Title: Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
Journal: Current heart failure reports 20110901
Title: The potential role for lixivaptan in heart failure and in hyponatremia.
Journal: Expert opinion on investigational drugs 20110601
Title: Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Journal: European journal of clinical pharmacology 20110401
Title: Lixivaptan, a non-peptide vasopressin V2 receptor antagonist for the potential oral treatment of hyponatremia.
Journal: IDrugs : the investigational drugs journal 20101101
Title: Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.
Journal: Clinical and translational science 20101001
Title: Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20100801
Title: The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists.
Journal: Journal of cardiac failure 20100501
Title: [Hyponatremia in heart failure: physiopathology and pharmacological approach].
Journal: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20100501
Title: [Vasopressin receptor antagonists: the vaptans].
Journal: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20100501
Title: Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure.
Journal: The Annals of pharmacotherapy 20100401
Title: [Vasopressin receptor antagonists and heart failure].
Journal: Therapeutische Umschau. Revue therapeutique 20091101
Title: Pharmacology of vasopressin antagonists.
Journal: Heart failure reviews 20090601
Title: AVP receptor antagonists in patients with CHF.
Journal: Heart failure reviews 20090601
Title: Treatment options for hyponatremia in heart failure.
Journal: Heart failure reviews 20090601
Title: Lixivaptan: a novel vasopressin receptor antagonist.
Journal: Expert opinion on investigational drugs 20090501
Title: [Etiology, diagnostics and therapy of hyponatremias].
Journal: Orvosi hetilap 20080720
Title: Vasopressin and vasopressin antagonists in heart failure and hyponatremia.
Journal: Current heart failure reports 20080601
Title: Vasopressin-receptor antagonists in heart failure.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080501
Title: Hyponatremia and vasopressin antagonism in congestive heart failure.
Journal: Clinical cardiology 20071101
Title: Identification and synthesis of major metabolites of Vasopressin V2-receptor agonist WAY-151932, and antagonist, Lixivaptan.
Journal: Bioorganic & medicinal chemistry letters 20071101
Title: Current issues for nurse practitioners: Hyponatremia.
Journal: Journal of the American Academy of Nurse Practitioners 20071101
Title: Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
Journal: Clinical therapeutics 20070201
Title: [Arginine vasopressin antagonism--new treatment option in chronic heart failure].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070118
Title: Therapeutic potential of vasopressin receptor antagonists.
Journal: Drugs 20070101
Title: AVP receptor antagonists as aquaretics: review and assessment of clinical data.
Journal: Cleveland Clinic journal of medicine 20060901
Title: Vasopressin antagonists.
Journal: Cellular and molecular life sciences : CMLS 20060801
Title: Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Journal: The American journal of medicine 20060701
Title: Vasopressin receptor antagonists.
Journal: Kidney international 20060601
Title: Vasopressin receptor antagonists in heart failure.
Journal: Recent patents on cardiovascular drug discovery 20060601
Title: Vasopressin excess and hyponatremia.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20060501
Title: (4-Substituted-phenyl)-(5H-10,11-dihydro-pyrrolo [2,1-c][1,4] benzodiazepin-10-yl)-methanone derivatives as vasopressin receptor modulators.
Journal: Bioorganic & medicinal chemistry letters 20051115
Title: Role of vasopressin antagonists in the management of acute decompensated heart failure.
Journal: Current heart failure reports 20050901
Title: Potent nonpeptide vasopressin receptor antagonists based on oxazino- and thiazinobenzodiazepine templates.
Journal: Bioorganic & medicinal chemistry letters 20040607
Title: Vasopressin receptor antagonists in heart failure.
Journal: Current opinion in pharmacology 20031201
Title: 2,5-disubstituted 3,4-dihydro-2H-benzo[b][1,4]thiazepines as potent and selective V2 arginine vasopressin receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters 20031117
Title: Structure-activity study of novel tricyclic benzazepine arginine vasopressin antagonists.
Journal: Bioorganic & medicinal chemistry letters 20030707
Title: Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Journal: Clinical science (London, England : 1979) 20030701
Title: Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.
Journal: Gastroenterology 20030401
Title: A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
Journal: Hepatology (Baltimore, Md.) 20030101
Title: Bridged bicyclic vasopressin receptor antagonists with V(2)-selective or dual V(1a)/V(2) activity.
Journal: Bioorganic & medicinal chemistry letters 20021104
Title: Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites.
Journal: Hepatology (Baltimore, Md.) 20021101
Title: Treatment of hyponatremic encephalopathy.
Journal: The Journal of laboratory and clinical medicine 20011201
Title: Treatment of hyponatremic encephalopathy with antagonists to antidiuretic hormone.
Journal: The Journal of laboratory and clinical medicine 20010701
Title: Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
Journal: The Journal of laboratory and clinical medicine 20010701
Title: Lixivaptan (American Home Products).
Journal: Current opinion in investigational drugs (London, England : 2000) 20010401
Title: 5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors.
Journal: Journal of medicinal chemistry 19980702
Title: Albright JD, et al. 5-Fluoro-2-methyl-N--(5H-pyrrolo,1-c-, 4benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenylbenzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors. J Med Chem. 1998 Jul 2;41(14):2442-4.
Title: Ghali JK, et al. Lixivaptan, a non-peptide vasopressin V2 receptor antagonist for the potential oral treatment of hyponatremia. IDrugs. 2010 Nov;13(11):782-92.
